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Desperate times call for desperate 
measures: Adapting antiretroviral 
service delivery in the context of the 
COVID-19 pandemic
To the Editor: On 23 March 2020, President Cyril Ramaphosa 
announced a nation-wide lockdown to help curb the spread of the 
COVID-19 epidemic in South Africa (SA). While these containment 
measures are considered to have limited the spread of COVID-19 in 
SA, the economic and social consequences, including the impact on 
healthcare service delivery, are prominent.
Regarding healthcare service delivery, there are concerns about 
people who could be at risk of experiencing severe COVID-19 
infection, and about meeting the needs of people with chronic 
diseases such as people living with HIV (PLHIV). In the context of 
the COVID-19 pandemic, PLHIV with an unsuppressed viral load 
may be at increased risk of developing severe COVID-19-related 
conditions and potentially dying, especially those who are co-infected 
with tuberculosis (TB). It is therefore important for PLHIV to avoid 
contact with individuals infected with COVID-19, while having 
access to antiretroviral therapy (ART). Although differentiated 
service delivery (DSD) models centred around clients’ needs and 
expectations and relieving unnecessary burdens on the health system, 
such as adherence clubs and quick pharmacy pick-up models, are 
now commonplace,[1] the COVID-19 containment measures have 
dramatically undermined the functioning of these services. 
To minimise the impact of the well-intended COVID-19 
containment measures on the HIV treatment outcomes of PLHIV, 
there is a critical need to adopt innovative approaches to sustain access 
to ART. The authors are involved in designing, implementing and 
monitoring differentiated approaches to maintaining decentralised 
access to ART for PLHIV in Western Cape Province. Herein, we 
describe the various DSD models currently adopted to overcome the 
challenges faced by PLHIV in accessing ART in the context of the 
COVID-19 containment measures.
When prepacked medications from the Central Dispensing Unit 
are received at the primary healthcare facility, the manifestos that 
come along with the prepacked medications are used to find the 
patients’ phone numbers and addresses in the electronic registry 
systems or patient folder. The patient is then contacted telephonically 
to verify their home address and where they would like their 
medication parcels to be delivered. Parcels for home delivery are then 
placed into boxes and delivered to the not-for-profit organisation 
(NPO) responsible for providing the community health services in 
the designated area for delivery.
Home delivery is the preferred delivery method and is offered 
to all PLHIV on ART, irrespective of how far from their treating 
facilities they live. Home deliveries aim to limit the need to attend 
a health facility for all patients. The call placed to patients is also a 
form of obtaining verbal consent. Verbal consent is required because 
not all PLHIV have disclosed their HIV status to their families 
owing to the potential of being stigmatised by family members and/
or neighbours. [2] If follow-up bloodwork is required, phlebotomy 
services are also deployed through the Uber model. The success of 
the home delivery approach of medication is dependent on verifying 
the patients’ addresses telephonically so that the community health 
workers (CHWs) do not waste efforts delivering to a patient who gave 
the wrong address or who is not in favour of home delivery.
When the phone call to assess the possibility of home delivery 
is made, some patients who have not disclosed their status to their 
family members opt to use their standard DSD model. Although 
DSD models such as adherence clubs, in which patients met as a 
group, are still operating, these models are now operated as de facto 
medication pick-up mechanisms, as club members are no longer 
required to sit as a group for facilitated discussions. While picking 
up medication, patients are required to always wear masks (cloth 
or surgical), as maintaining the recommended 2 m distance from 
each other may be challenging because facilities do not have very 
wide halls.[3] Hand sanitisers are also provided at the entrance to 
the healthcare facilities.
For PLHIV who do not want their medications to be delivered 
at home or to go to the clinic for collection, arrangements are 
made for their medication to be delivered at a community-based 
designated location, usually church premises, town/community 
halls or NPO offices. Community-based venues are also used when 
an area is deemed too dangerous for CHWs to do door-to-door 
home deliveries. While picking up their medications, patients are 
also expected to maintain social distancing measures.[4]
Home delivery is also done for PLHIV who are quarantined 
at home. For PLHIV who are in isolation centres and forgot to 
collect their medication refill before isolation, arrangements are 
made for their medication to be dropped by the nurse manning 
the isolation centre. Deliveries at isolation centres are co-ordinated 
at a higher administrative level rather than at the facility level. 
Usually, the patient reaches out to healthcare workers at their usual 
treatment facilities, who then communicate with the substructure to 
co-ordinate the efforts to provide ART for patients in isolation.
For PLHIV who are also on TB treatment, rather than have a 
healthcare professional conduct directly observed therapy (DOT), 
the patients are assessed in terms of whether a family member is 
available to support DOT or are referred to NPOs for community-
based support if available. The clinicians then provide 2 weeks’ supply 
of medication (supplying a pillbox if available) and schedule a follow-
up appointment, as opposed to 1 week’s medication.  The patient’s 
and family member’s contact details are recorded and supplied to the 
facility for confirmation.
For patients who previously received their medication packages at 
a facility close to their workplaces, having their medication delivered 
to their homes is a challenge as they may live out of the designated 
jurisdiction of the CHWs/NPO, or even in another substructure. 
An area for improvement is a collaboration between various NPOs 
and/or substructures to assist with these patients also having their 
medications delivered to their homes if they give permission.
For PLHIV who the facility fails to contact, their medications are 
kept at the facility for collection.
In conclusion, we encourage other health systems to consider 
adopting such patient-centred and context-relevant approaches while 
upholding the COVID-19 containment measures.
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